- Home
- SXTC vs ONCO Comparison
SXTC vs ONCO Comparison
Compare SXTC & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTC
- ONCO
- Stock Information
- Founded
- SXTC 2005
- ONCO 2018
- Country
- SXTC China
- ONCO United States
- Employees
- SXTC N/A
- ONCO N/A
- Industry
- SXTC Biotechnology: Pharmaceutical Preparations
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- SXTC Health Care
- ONCO Health Care
- Exchange
- SXTC Nasdaq
- ONCO Nasdaq
- Market Cap
- SXTC N/A
- ONCO 1.8M
- IPO Year
- SXTC 2019
- ONCO 2022
- Fundamental
- Price
- SXTC $2.57
- ONCO $0.07
- Analyst Decision
- SXTC
- ONCO
- Analyst Count
- SXTC 0
- ONCO 0
- Target Price
- SXTC N/A
- ONCO N/A
- AVG Volume (30 Days)
- SXTC 1.6M
- ONCO 9.2M
- Earning Date
- SXTC 01-01-0001
- ONCO 05-19-2025
- Dividend Yield
- SXTC N/A
- ONCO N/A
- EPS Growth
- SXTC N/A
- ONCO N/A
- EPS
- SXTC N/A
- ONCO N/A
- Revenue
- SXTC $1,928,497.00
- ONCO $1,870,605.00
- Revenue This Year
- SXTC N/A
- ONCO N/A
- Revenue Next Year
- SXTC N/A
- ONCO N/A
- P/E Ratio
- SXTC N/A
- ONCO N/A
- Revenue Growth
- SXTC N/A
- ONCO N/A
- 52 Week Low
- SXTC $2.40
- ONCO $0.07
- 52 Week High
- SXTC $26.96
- ONCO $21.40
- Technical
- Relative Strength Index (RSI)
- SXTC 48.21
- ONCO 17.45
- Support Level
- SXTC $2.66
- ONCO $0.07
- Resistance Level
- SXTC $3.09
- ONCO $0.15
- Average True Range (ATR)
- SXTC 0.23
- ONCO 0.02
- MACD
- SXTC -0.14
- ONCO 0.01
- Stochastic Oscillator
- SXTC 18.55
- ONCO 9.41
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.